Angiogenesis Inhibitors

All categories
DBCAT000222Pharmacologic class

Agents and endogenous substances that antagonize or inhibit the development of new blood vessels. A DrugBank category of 29 drugs. 11 of them are approved.

Also known as
Agents, Angiostatic · Agents, Anti-Angiogenetic · Agents, Antiangiogenic · Angiogenesis Factor Inhibitors · Angiogenetic Antagonists
Drugs

and 4 more with a free account

What you can answer from here — as of May 25, 2021

29DrugsEach linked to its full drug card
Sign in
93Drug targetsEvery drug–target pair in the class, with bond type
Sign in
2,099Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
9Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Angiogenesis Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In